
Overview
Stanley Marks, MD, specializes in hematology oncology and medical oncology and is board-certified in hematology and internal medicine by the American Board of Internal medicine. Dr. Marks completed his medical degree at the University of Pittsburgh School of Medicine. He completed his residency training at Presbyterian Hospital, and fellowship training in clinical medicine and research medicine at Peter Bent Brigham Hospital, Harvard Medical School and Dana Farber Cancer Center. He has received numerous awards including the Golden Apple Award for Outstanding Dedication to Housestaff Education from Allegheny General Hospital, Hillel Academy Outstanding Alumnus, and The Winged Victory of Samothrace Award from the Leukemia, Lymphoma Society of Western Pennsylvania.
Dr. Marks is highly rated in 18 conditions, according to our data. His clinical expertise encompasses Non-Hodgkin Lymphoma, Primary Lymphoma of the Brain, Gastric Lymphoma, and Follicular Lymphoma.
Dr. Marks is board certified in American Board Of Internal Medicine and American Board Of Internal Medicine. He is actively involved in clinical research, co-authoring 9 peer reviewed articles and participating in 1 clinical trial. Dr. Marks is currently accepting new patients.
Specialties
Licenses
Board Certifications
Fellowships
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE SNP
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- OTHER MANAGED MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- HMO
- MANAGED MEDICAID PLAN
- EPO
- HMO
- POS
- PPO
- EPO
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
1500 5th Avenue, Mckeesport, PA 15132
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
UPMC Hillman Cancer Center
Melissa Burgess, MD, is an assistant professor at the University of Pittsburgh School of Medicine and a medical oncologist. She specializes in the treatment of soft tissue and bone sarcomas and Merkel cell carcinoma. Dr. Burgess is highly rated in 41 conditions, according to our data. Her clinical expertise encompasses Adult Soft Tissue Sarcoma, Liposarcoma, Merkel Cell Carcinoma, Chondrosarcoma, and Gamma Knife Radiosurgery. Dr. Burgess is board certified in American Board Of Internal Medicine. Dr. Burgess is currently accepting new patients.
UPMC Hillman Cancer Center
Adam M. Brufsky, MD, PhD, FACP, is professor of medicine at the University of Pittsburgh School of Medicine and also serves as the associate division chief for the Division of Hematology/Oncology at the University of Pittsburgh School of Medicine's Department of Medicine. Dr. Brufsky is the medical director of the Magee-Women's Cancer Program, part of the UPMC Hillman Cancer Center, and UPMC Hillman Cancer Center; associate director for clinical investigations at UPMC Hillman Cancer Center; and codirector of the Comprehensive Breast Cancer Center.Dr. Brufsky is board-certified in internal medicine and medical oncology. He earned a medical and doctor of philosophy degrees from the University of Connecticut School of Medicine in Farmington, Conn.; completed a residency at Brigham and Women's Hospital, Harvard Medical School, and a fellowship at Dana-Farber Cancer Institute.Dr. Brufsky is a member of professional organizations, such as American Medical Association, Massachusetts Medical Society, American College of Physicians, American Society of Clinical Oncology, American Association for Cancer Research, Allegheny County Medical Society, Pennsylvania Medical Society, and Pennsylvania Oncologic Society. An active researcher, Dr. Brufsky has numerous abstracts and research articles in leading journals, and is principal investigator on a number of research grants funded by the National Institutes of Health, Susan G. Komen Foundation, and US Army - Breast Cancer Research Program. Dr. Brufsky is highly rated in 16 conditions, according to our data. His clinical expertise encompasses Breast Cancer, Triple-Negative Breast Cancer, Inflammatory Breast Cancer, Breast Cancer in Men, and Gastrostomy. Dr. Brufsky is board certified in American Board Of Internal Medicine and American Board Of Internal Medicine. Dr. Brufsky is currently accepting new patients.
UPMC Hillman Cancer Center
Liza C. Villaruz, MD, is board-certified in medical oncology and hematology at UPMC Hillman Cancer Center, and she specializes in lung cancer and thoracic malignancies. Dr. Villaruz is highly rated in 13 conditions, according to our data. Her clinical expertise encompasses Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, EGFR Positive Lung Cancer, and Small Cell Lung Cancer (SCLC). Dr. Villaruz is board certified in American Board Of Internal Medicine. Dr. Villaruz is currently accepting new patients.
Frequently Asked Questions about Dr. Stanley M. Marks
How do I make an appointment with Dr. Stanley M. Marks?
You can book an appointment with Dr. Stanley M. Marks by calling their office at 412-664-2607. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Stanley M. Marks a top-rated expert for Non-Hodgkin Lymphoma?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Stanley M. Marks is classified as an Distinguished expert for Non-Hodgkin Lymphoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Stanley M. Marks specialize in?
While Dr. Stanley M. Marks is a Hematology Oncology, they have specific expertise in Non-Hodgkin Lymphoma, Primary Lymphoma of the Brain, and Gastric Lymphoma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology Oncology.
Does Dr. Stanley M. Marks participate in research or clinical trials?
Yes. Dr. Stanley M. Marks has published 9 articles and abstracts on conditions like Non-Hodgkin Lymphoma. You can view a list of Dr. Stanley M. Marks's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Stanley M. Marks accept my insurance?
Dr. Stanley M. Marks accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 412-664-2607 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Gastric LymphomaDr. Marks isDistinguished. Learn about Gastric Lymphoma.
- Non-Hodgkin LymphomaDr. Marks isDistinguished. Learn about Non-Hodgkin Lymphoma.
- Primary Lymphoma of the BrainDr. Marks isDistinguished. Learn about Primary Lymphoma of the Brain.
- Advanced
- B-Cell LymphomaDr. Marks isAdvanced. Learn about B-Cell Lymphoma.
- Breast CancerDr. Marks isAdvanced. Learn about Breast Cancer.
- Chronic B-Cell Leukemia (CBCL)Dr. Marks isAdvanced. Learn about Chronic B-Cell Leukemia (CBCL).
- Chronic Lymphocytic Leukemia (CLL)
- Classical Hodgkin LymphomaDr. Marks isAdvanced. Learn about Classical Hodgkin Lymphoma.
- Follicular LymphomaDr. Marks isAdvanced. Learn about Follicular Lymphoma.
- Hemangioma Thrombocytopenia Syndrome
- Hodgkin LymphomaDr. Marks isAdvanced. Learn about Hodgkin Lymphoma.
- Inflammatory Breast CancerDr. Marks isAdvanced. Learn about Inflammatory Breast Cancer.
- Lung CancerDr. Marks isAdvanced. Learn about Lung Cancer.
- Mantle Cell Lymphoma (MCL)Dr. Marks isAdvanced. Learn about Mantle Cell Lymphoma (MCL).
- Paget Disease of the BreastDr. Marks isAdvanced. Learn about Paget Disease of the Breast.
- Pleuropulmonary BlastomaDr. Marks isAdvanced. Learn about Pleuropulmonary Blastoma.
- Richter SyndromeDr. Marks isAdvanced. Learn about Richter Syndrome.
- Small Lymphocytic Lymphoma (SLL)
- Experienced
- Acinic Cell Carcinoma of Salivary Glands
- Acute Lymphoblastic Leukemia (ALL)Dr. Marks isExperienced. Learn about Acute Lymphoblastic Leukemia (ALL).
- Adenoid Cystic CarcinomaDr. Marks isExperienced. Learn about Adenoid Cystic Carcinoma.
- Adrenal CancerDr. Marks isExperienced. Learn about Adrenal Cancer.
- AgranulocytosisDr. Marks isExperienced. Learn about Agranulocytosis.
- ALK-Positive Non-Small Cell Lung Cancer
- AnemiaDr. Marks isExperienced. Learn about Anemia.
- AngiosarcomaDr. Marks isExperienced. Learn about Angiosarcoma.
- Beta ThalassemiaDr. Marks isExperienced. Learn about Beta Thalassemia.
- Breast Cancer in MenDr. Marks isExperienced. Learn about Breast Cancer in Men.
- Childhood Acute Myeloid LeukemiaDr. Marks isExperienced. Learn about Childhood Acute Myeloid Leukemia.
- Childhood Iron Deficiency AnemiaDr. Marks isExperienced. Learn about Childhood Iron Deficiency Anemia.
- ChondrosarcomaDr. Marks isExperienced. Learn about Chondrosarcoma.
- Chronic Familial NeutropeniaDr. Marks isExperienced. Learn about Chronic Familial Neutropenia.
- Chronic Myelogenous Leukemia (CML)Dr. Marks isExperienced. Learn about Chronic Myelogenous Leukemia (CML).
- Diffuse Large B-Cell Lymphoma (DLBCL)Dr. Marks isExperienced. Learn about Diffuse Large B-Cell Lymphoma (DLBCL).
- Drug-Induced ThrombocytopeniaDr. Marks isExperienced. Learn about Drug-Induced Thrombocytopenia.
- EGFR Positive Lung CancerDr. Marks isExperienced. Learn about EGFR Positive Lung Cancer.
- Epidermal NevusDr. Marks isExperienced. Learn about Epidermal Nevus.
- Ewing SarcomaDr. Marks isExperienced. Learn about Ewing Sarcoma.
- GangliogliomaDr. Marks isExperienced. Learn about Ganglioglioma.
- Hairy Cell Leukemia (HCL)Dr. Marks isExperienced. Learn about Hairy Cell Leukemia (HCL).
- Hemophagocytic LymphohistiocytosisDr. Marks isExperienced. Learn about Hemophagocytic Lymphohistiocytosis.
- HemosiderosisDr. Marks isExperienced. Learn about Hemosiderosis.
- HistiocytosisDr. Marks isExperienced. Learn about Histiocytosis.
- Idiopathic Pulmonary HemosiderosisDr. Marks isExperienced. Learn about Idiopathic Pulmonary Hemosiderosis.
- Intraductal PapillomaDr. Marks isExperienced. Learn about Intraductal Papilloma.
- Iron Deficiency AnemiaDr. Marks isExperienced. Learn about Iron Deficiency Anemia.
- Large-Cell Immunoblastic LymphomaDr. Marks isExperienced. Learn about Large-Cell Immunoblastic Lymphoma.
- Large-Cell Lung CarcinomaDr. Marks isExperienced. Learn about Large-Cell Lung Carcinoma.
- LeukemiaDr. Marks isExperienced. Learn about Leukemia.
- Lung AdenocarcinomaDr. Marks isExperienced. Learn about Lung Adenocarcinoma.
- Lymphofollicular HyperplasiaDr. Marks isExperienced. Learn about Lymphofollicular Hyperplasia.
- Lynch SyndromeDr. Marks isExperienced. Learn about Lynch Syndrome.
- Marginal Zone Lymphoma (MZL)Dr. Marks isExperienced. Learn about Marginal Zone Lymphoma (MZL).
- Monoclonal Gammopathy of Undetermined Significance (MGUS)
- Multiple MyelomaDr. Marks isExperienced. Learn about Multiple Myeloma.
- Myelodysplastic Syndrome (MDS)Dr. Marks isExperienced. Learn about Myelodysplastic Syndrome (MDS).
- Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)
- Non-Langerhans-Cell HistiocytosisDr. Marks isExperienced. Learn about Non-Langerhans-Cell Histiocytosis.
- Non-Small Cell Lung Cancer (NSCLC)Dr. Marks isExperienced. Learn about Non-Small Cell Lung Cancer (NSCLC).
- OsteosarcomaDr. Marks isExperienced. Learn about Osteosarcoma.
- Philadelphia-Negative Chronic Myeloid Leukemia
- Polycythemia VeraDr. Marks isExperienced. Learn about Polycythemia Vera.
- ReticuloendotheliosisDr. Marks isExperienced. Learn about Reticuloendotheliosis.
- ReticulohistiocytomaDr. Marks isExperienced. Learn about Reticulohistiocytoma.
- Salivary Gland TumorsDr. Marks isExperienced. Learn about Salivary Gland Tumors.
- Schnitzler SyndromeDr. Marks isExperienced. Learn about Schnitzler Syndrome.
- Severe Congenital NeutropeniaDr. Marks isExperienced. Learn about Severe Congenital Neutropenia.
- Shwartzman PhenomenonDr. Marks isExperienced. Learn about Shwartzman Phenomenon.
- Small Cell Lung Cancer (SCLC)Dr. Marks isExperienced. Learn about Small Cell Lung Cancer (SCLC).
- Smoldering Multiple MyelomaDr. Marks isExperienced. Learn about Smoldering Multiple Myeloma.
- Squamous Cell Lung CarcinomaDr. Marks isExperienced. Learn about Squamous Cell Lung Carcinoma.
- ThrombocytopeniaDr. Marks isExperienced. Learn about Thrombocytopenia.
- Venous Thromboembolism (VTE)Dr. Marks isExperienced. Learn about Venous Thromboembolism (VTE).
- Waldenstrom MacroglobulinemiaDr. Marks isExperienced. Learn about Waldenstrom Macroglobulinemia.


